MARKET

TCBPY

TCBPY

TC BioPharm (Holdings) Ltd
OTCPK
0.071
0.000
0.28%
Closed 15:32 02/09 EST
OPEN
0.071
PREV CLOSE
0.071
HIGH
0.071
LOW
0.071
VOLUME
126
TURNOVER
9
52 WEEK HIGH
4.690
52 WEEK LOW
0.050
MARKET CAP
149.74K
P/E (TTM)
-0.0004
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TCBPY last week (0202-0206)?
Weekly Report · 17h ago
Weekly Report: what happened at TCBPY last week (0126-0130)?
Weekly Report · 02/02 10:08
Weekly Report: what happened at TCBPY last week (0119-0123)?
Weekly Report · 01/26 10:07
Weekly Report: what happened at TCBPY last week (0112-0116)?
Weekly Report · 01/19 10:13
Weekly Report: what happened at TCBPY last week (0105-0109)?
Weekly Report · 01/12 10:12
Weekly Report: what happened at TCBPY last week (1229-0102)?
Weekly Report · 01/05 10:07
Weekly Report: what happened at TCBPY last week (1222-1226)?
Weekly Report · 12/29/2025 10:06
Weekly Report: what happened at TCBPY last week (1215-1219)?
Weekly Report · 12/22/2025 10:06
More
About TCBPY
TC BioPharm (Holdings) plc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T (GD-T) cell therapies for the treatment of cancer with human efficacy data in acute myeloid leukemia (AML). The Company is conducting two investigator-initiated clinical trials for its unmodified GD-T cell product line - phase IIb/III pivotal trial in treatment of AML using its allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product candidate, OmnImmune is an unmodified allogeneic GD-T cell product, being initially used for the treatment of AML. Its pre-clinical stage program is focused on developing CAR-modified allogeneic GD-T cell products targeting solid and hematological indications. It has an Israeli patent and Japanese patent applications covering the method of preparing and using GD-T cells in the allogeneic treatment of subjects suffering from viral, fungal and protozoal infections or cancer.

Webull offers TC Biopharm (Holdings) PLC - ADR stock information, including OTCPK: TCBPY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCBPY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCBPY stock methods without spending real money on the virtual paper trading platform.